Critical role of Fas/Fas ligand interaction in CD28‐independent pathway of allogeneic murine hepatocyte rejection

Cytolytic induction of T cells requires both the T‐cell receptor (TCR)‐mediated antigenic stimulation and the CD28‐mediated co‐stimulatory signal. Blockade of the interactions between CD28 and its ligands, CD80 and CD86, prolongs the survival of allografts in some transplantation models. However, we found that allogeneic hepatocytes were completely rejected within 7 days after intrasplenic transplantation, even when treated with monoclonal antibodies (mAbs) against CD80 and CD86 (anti‐CD80/86). Recent studies have shown that there are two main mechanisms of T‐cell‐mediated cytotoxicity, perforin‐based and Fas‐based ones. It has been shown that the liver is highly sensitive to induction of apoptosis by an agonistic anti‐Fas mAb. We then investigated the role of the Fas/Fas ligand (FasL) system in the CD28‐independent allogeneic hepatocyte rejection. With the anti‐CD80/86 mAb treatment, hepatocytes from C57BL/6 lpr/lpr (B6 lpr) mice, which express little Fas antigen, could survive for 7 days after intrasplenic transplantation, and hepatocytes from C57BL/6 (B6) mice could also survive for 7 days in the spleen of C3H/ He gld/gld (C3H gld) mice, which express no functional FasL. CD28‐independent induction of cytotoxicity against allogeneic hepatocytes was not observed when the effector cells were derived from C3H gld mice. These results indicated that the Fas/FasL system plays a critical role in the CD28‐independent pathway of allogeneic hepatocyte rejection.

[1]  K. Okumura,et al.  Contribution of Fas ligand to cardiac allograft rejection. , 1996, International immunology.

[2]  G. Freeman,et al.  Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-1 antibodies. , 1995, Transplantation.

[3]  M. Azuma,et al.  Preferential dependence of autoantibody production in murine lupus on CD86 costimulatory molecule , 1995, European journal of immunology.

[4]  P. Galle,et al.  Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage , 1995, The Journal of experimental medicine.

[5]  S. Hanabuchi,et al.  Fas‐mediated Cytotoxicity ‐ A New Immunoregulatory and Pathogenic Function of Thl CD4+ T Cells , 1995, Immunological reviews.

[6]  S. Nagata,et al.  The Fas death factor , 1995, Science.

[7]  S. Nagata,et al.  TCR/CD3 coupling to Fas-based cytotoxicity , 1995, The Journal of experimental medicine.

[8]  S. Nagata,et al.  Fas-mediated apoptosis in primary cultured mouse hepatocytes. , 1994, Experimental cell research.

[9]  P. Golstein,et al.  T cell receptor‐induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A , 1994, European journal of immunology.

[10]  H Hengartner,et al.  Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. , 1994, Science.

[11]  J. Bluestone,et al.  The B7 and CD28 receptor families. , 1994, Immunology today.

[12]  S. Yonehara,et al.  Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Terry Farrah,et al.  The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death , 1994, Cell.

[14]  Takashi Suda,et al.  Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor family , 1993, Cell.

[15]  N. Hayashi,et al.  Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C , 1993, Hepatology.

[16]  S. Nagata,et al.  Lethal effect of the anti-Fas antibody in mice , 1993, Nature.

[17]  L. Lanier,et al.  Requirements for CD28-dependent T cell-mediated cytotoxicity. , 1993, Journal of immunology.

[18]  P. Linsley,et al.  T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[19]  P. Linsley,et al.  Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. , 1992, Science.

[20]  M. Isobe,et al.  Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. , 1992, Science.

[21]  R. Schwartz,et al.  A cell culture model for T lymphocyte clonal anergy. , 1990, Science.

[22]  T. Decker,et al.  A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. , 1988, Journal of immunological methods.

[23]  D. Sutherland,et al.  Prospects for hepatocyte transplantation , 1988, Hepatology.

[24]  M. Mito,et al.  Rejection of allogeneic hepatocytes and fetal hepatic tissue transplanted into the rat spleen. , 1985, Transplantation.

[25]  M. Kusano,et al.  Morphology and function of isolated hepatocytes transplanted into rat spleen. , 1979 .

[26]  P. Bretscher.  The two-signal model of lymphocyte activation twenty-one years later. , 1992, Immunology today.

[27]  Y. Shinkai,et al.  Role of perforin in lymphocyte-mediated cytolysis. , 1992, Advances in immunology.

[28]  R. Schwartz,et al.  Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. , 1989, Annual review of immunology.